Toh ZQ, Kosasih J, Russell FM, Garland SM, Mulholland EK, Licciardi PV. Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus. Infect Drug Resist. 2019;12:1951–67. https://doi.org/10.2147/IDR.S178381.
Article CAS PubMed PubMed Central Google Scholar
Stelzle D, Tanaka LF, Lee KK, Khalil AI, Baussano I, Shah AS, Dalal S. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161–9. https://doi.org/10.1016/S2214-109X(20)30459-9.
Article CAS PubMed Google Scholar
Schiffman M, Doorbar J, Wentzensen N, De Sanjosé S, Fakhry C, Monk BJ, Franceschi S. Carcinogenic human papillomavirus infection. Nat Rev Dis Primers. 2016;2(1):1–20. https://doi.org/10.1038/nrdp.2016.86.
De Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17–27. https://doi.org/10.1016/j.virol.2004.03.033.
Article CAS PubMed Google Scholar
Berti FCB, Pereira APL, Cebinelli GCM, Trugilo KP, de Oliveira KB. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma. Cytokine Growth Factor Rev. 2017;34:1–13. https://doi.org/10.1016/j.cytogfr.2017.03.002.
Article CAS PubMed Google Scholar
De Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453–9. https://doi.org/10.1016/S1473-3099(07)70158-5.
Wang X, Huang X, Zhang Y. Involvement of human papillomaviruses in cervical cancer. Front Microbiol. 2018;9:2896.
Article PubMed PubMed Central Google Scholar
Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, Rohan TE. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180(5):1415–23. https://doi.org/10.1086/315086.
Article CAS PubMed Google Scholar
Ghebre RG, Grover S, Xu MJ, Chuang LT, Simonds H. Cervical cancer control in HIV-infected women: past, present and future. Gynecol Oncol Rep. 2017;21:101–8. https://doi.org/10.1016/j.gore.2017.07.009.
Article PubMed PubMed Central Google Scholar
de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70.
Article PubMed PubMed Central Google Scholar
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–203. https://doi.org/10.1016/S2214-109X(19)30482-6.
Prabhu M, Eckert LO. Development of World Health Organization (WHO) recommendations for appropriate clinical trial endpoints for next-generation Human Papillomavirus (HPV) vaccines. Papillomavirus Res. 2016;2:185–9. https://doi.org/10.1016/j.pvr.2016.10.002.
Article PubMed PubMed Central Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.
Olorunfemi G, Ndlovu N, Masukume G, Chikandiwa A, Pisa PT, Singh E. Temporal trends in the epidemiology of cervical cancer in South Africa (1994–2012). Int J Cancer. 2018;143(9):2238–49. https://doi.org/10.1002/ijc.31610.
Article CAS PubMed PubMed Central Google Scholar
Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, Gaffney DK. Cervical cancer: a global health crisis. Cancer. 2017;123(13):2404–12. https://doi.org/10.1002/cncr.30667.
Pimple SA, Mishra GA. Global strategies for cervical cancer prevention and screening. Minerva Ginecol. 2019;71(4):313–20. https://doi.org/10.23736/s0026-4784.19.04397-1.
World Health Organization. A cervical cancer-free future: first-ever global commitment to eliminate a cancer. 2020.
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169–82. https://doi.org/10.1016/S0140-6736(18)32470-X.
Yuan Y, Cai X, Shen F, Ma F. HPV post-infection microenvironment and cervical cancer. Cancer Lett. 2020. https://doi.org/10.1016/j.canlet.2020.10.034.
Article PubMed PubMed Central Google Scholar
Roura E, Castellsagué X, Pawlita M, Travier N, Waterboer T, Margall N, Riboli E. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer. 2014;135(2):453–66. https://doi.org/10.1002/ijc.28666.
Article CAS PubMed Google Scholar
Louie KS, De Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Tropical Med Int Health. 2009;14(10):1287–302. https://doi.org/10.1111/j.1365-3156.2009.02372.x.
Ghosh I, Mandal R, Kundu P, Biswas J. Association of genital infections other than human papillomavirus with pre-invasive and invasive cervical neoplasia. J Clin Diagn Res. 2016;10(2):XE01–6. https://doi.org/10.7860/JCDR/2016/15305.7173.
Article CAS PubMed PubMed Central Google Scholar
Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889–99. https://doi.org/10.1016/S0140-6736(13)60022-7.
Mittal S, Banks L. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation. Mutat Res Rev Mutat Res. 2017;772:23–35. https://doi.org/10.1016/j.mrrev.2016.08.001.
Article CAS PubMed Google Scholar
Prue G, Baker P, Graham D, Nutting C, Greenhouse P, Lawler M. It is time for universal HPV vaccination. Lancet. 2018;392(10151):913–4. https://doi.org/10.1016/S0140-6736(18)31821-X.
Sichero L, Picconi MA, Villa LL. The contribution of Latin American research to HPV epidemiology and natural history knowledge. Braz J Med Biol Res. 2020. https://doi.org/10.1590/1414-431X20199560.
Article PubMed PubMed Central Google Scholar
Gibb RK, Martens MG. The impact of liquid-based cytology in decreasing the incidence of cervical cancer. Rev Obstet Gynecol. 2011;4(Suppl 1):S2–11. https://doi.org/10.3909/riogV4S1S0002.
Article PubMed PubMed Central Google Scholar
Harari A, Chen Z, Burk RD. Human papillomavirus genomics: past, present and future. In: Ramírez-Fort MK, Khan F, Rady PL, Tyring SK, editors. Human papillomavirus. Basel: Karger Publishers; 2014. p. 1–18. https://doi.org/10.1159/000355952.
Conway C, Chalkley R, High A, Maclennan K, Berri S, Chengot P, Wood HM. Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors. J Mol Diagnostics. 2012; 14(2):104–111. https://www.sciencedirect.com/science/article/pii/S1525157811003138#!
Bhatla N, Singhal S. Primary HPV screening for cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2020;65:98–108. https://doi.org/10.1016/j.bpobgyn.2020.02.008.
Chrysostomou AC, Kostrikis LG. Methodologies of primary HPV testing currently applied for cervical cancer screening. Life. 2020;10(11):290. https://doi.org/10.3390/life10110290.
Article CAS PubMed PubMed Central Google Scholar
Tjalma WAA, Depuydt CE. Cervical cancer screening: which HPV test should be used—L1 or E6/E7? EurJ Obstet Gynecol Reprod Biol. 2013;170(1):45–6. https://doi.org/10.1016/j.ejogrb.2013.06.027.
Poljak M, Valenčak AO, Domjanič GG, Xu L, Arbyn M. Commercially available molecular tests for human papillomaviruses: a global overview. Clin Microbiol Infect. 2020. https://doi.org/10.1016/j.cmi.2020.03.033.
Article PubMed PubMed Central Google Scholar
Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C. American cancer society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52(6):342–62. https://doi.org/10.3322/canjclin.52.6.342.
Aravindakshan TV, Nainar AM, Nachimuthu K. High salt method: a simple and rapid procedure for isolation of genomic DNA from buffalo (Bubalus bubalis) white blood cells. Indian J Exp Biol. 1997;35(8):903–5.
Chatterjee S, Chattopadhyay A, Samanta L. HPV and cervical cancer epidemiology-current status of HPV vaccination in India. Asian Pac J Cancer Prev. 2016;17(8):3663–73.
Dürst M, Gissmann L, Ikenberg H, Zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci. 1983;80(12):3812–5. https://doi.org/10.1073/pnas.80.12.3812.
Article PubMed PubMed Central Google Scholar
Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen, H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984;3(5):1151–7. https://doi.org/10.1002/j.1460-2075.1984.tb01944.x.
留言 (0)